Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cefoxitin + gentamicin is a combination of two antibiotics used together for the treatment of serious bacterial infections, particularly in hospital settings. Cefoxitin is a second-generation cephamycin antibiotic that acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It has broad-spectrum activity against both aerobic and anaerobic bacteria. Gentamicin is an aminoglycoside antibiotic that binds to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis and resulting in bactericidal activity, especially against gram-negative organisms. This combination may be used empirically or when mixed infections are suspected, such as intra-abdominal or pelvic infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cefoxitin + gentamicin.